Drug intelligence / Profile preview

lidocaine + ketorolac

Development stage
Unknown
Lead developer
IT3 Medical
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Percutaneous, Topical
01

Overview

**Lidocaine + ketorolac** is a non-opioid analgesic combination consisting of lidocaine, an amide local anesthetic, and ketorolac, a nonsteroidal anti-inflammatory drug. Lidocaine inhibits neuronal voltage-gated sodium-channel ion flux to prevent initiation and propagation of nociceptive impulses, while ketorolac reversibly inhibits cyclooxygenase-1 and cyclooxygenase-2, reducing prostaglandin-mediated pain and inflammation. The combination has been administered together in local and regional anesthesia, intravenous regional anesthesia, perioperative analgesia, and procedural pain-management settings. In the United States, IT3 Medical markets co-packaged lidocaine hydrochloride and ketorolac tromethamine kits as Acunistat-30 and Acunistat-60 under abbreviated new drug applications. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fad54f13-52a6-4c4b-9120-46bfffe2808e))

Brand names
Acunistat-30Acunistat30Acunistat 30Acunistat-60Acunistat60Acunistat 60
Other names
ketorolac + lidocaineketorolac-lidocainelidocaine + ketorolaclidocaine and ketorolaclidocaine hydrochloride + ketorolac tromethaminelidocaine-ketorolaclidocaine/ketorolac
02

Targets

NaV alpha (Voltage-gated sodium channel alpha subunit family)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on lidocaine + ketorolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + ketorolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call